Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 2, 2013, Pages 151-161

  Varela, E ^a   Manichanh, C ^a   Gallart, M ^a   Torrejon A ^a   Borruel, N ^a   Casellas, F ^a   Guarner, F ^a   Antolin, M ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALGRANULIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; FAECALIBACTERIUM PRAUSNITZII; FECES MICROFLORA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION ABUNDANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; RELATIVE; REMISSION; ULCERATIVE COLITIS; CROSS-SECTIONAL STUDY; FECES; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PEDIGREE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; RUMINOCOCCUS; YOUNG ADULT;

ADULT; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; FECES; FEMALE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PEDIGREE; REAL-TIME POLYMERASE CHAIN REACTION; RECURRENCE; RUMINOCOCCUS; YOUNG ADULT;

EID: 84879238231     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12365     Document Type: Article

References (37)

1. Sartor RB,. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
2. Marteau P,. Bacterial flora in inflammatory bowel disease. Dig Dis 2009; 27 (Suppl. 1): 99-103.
3. Flanagan P, Campbell BJ, Rhodes JM,. Bacteria in the pathogenesis of inflammatory bowel disease. Biochem Soc Trans 2011; 39: 1067-72.
4. Swidsinski P, Sokol H, Lepage P, et al,. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 118.
5. Swidsinski A, Ladhoff A, Pernthaler A, et al,. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44-55.
6. Bibiloni R, Mangold M, Madsen K, Fedorak RN, Tannock GW,. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55: 1141-9.
7. Sepehri S, Kotlowski R, Bernstein CN, Krause DO,. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 675-83.
8. Martinez C, Antolin M, Santos J, et al,. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol 2008; 103: 643-8.
9. Frank DN, Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR,. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS 2007; 104: 13780-5.
10. Fava F, Danese S,. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011; 17: 557-66.
11. Seksik P,. Gut microbiota and IBD. Gastroenterol Clin Biol 2010; 34 (Suppl. 1): S44-51.
12. Lepage P, Häsler R, Spehlmann ME, et al,. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011; 2011: 227-36.
13. Arumugan M, Raes J, Pelletier E, et al,. Enterotypes of the human gut microbioma. Nature 2011; 473: 174-80.
14. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ,. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 2006; 12: 1136-45.
15. Willing B, Halfvaeson J, Dicksved J, et al,. Twin studies reveal specific imbalances in the mucosa.associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009; 15: 653-60.
16. Joossens M, Huys G, Cnockaert M, et al,. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60: 631-7.
17. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y,. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008; 14: 147-61.
18. Jia W, Whitehead R, Griffiths L, et al,. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 2010; 310: 138-44.
19. Sokol H, Pigneur B, Watterlot L, et al,. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. PNAS 2008; 105: 16731-6.
20. Sokol H, Seksik P, Furet JP, et al,. Low counts of Faecalibacterium prausnitzii in colitis Microbiota. Inflamm Bowel Dis 2009; 15: 1183-9.
21. Vermeiren J, Van den Abbeele P, Laukens D, et al,. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol Ecol 2012; 79: 685-96.
22. Rachmilewitz D,. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ 1989; 298: 82-6.
23. Godon JJ, Zumstein E, Dabert P, Habouzit F, Moletta R,. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 1997; 63: 2802-13.
24. Manichanh C, Reeder J, Gibert P, et al,. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 2010; 20: 1411-9.
25. Hansen R, Russell R, Reiff C, et al,. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012; 107: 1913-22.
26. Morgan X C, Tickle TL, Sokol H, et al,. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: R79.
27. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S,. 2008 Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008; 14: 968-76.
28. Li E, Hamm C, Gulati A, et al,. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS ONE 2012; 7: e26284.
29. Gorkiewicz G, Thallinger G, Trajanoski S, et al,. Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS One 2013; 8: e55817.
30. Bullock NR, Booth JC, Gibson GR,. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr Issues Intest Microbiol 2004; 5: 59-64.
31. Benus R, van der Werf T, Welling G,. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr 2010; 104: 693-700.
32. Galvez J, Rodríguez-Cabezas ME, Zarzuelo A,. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 2005; 49: 601-8.
33. Lara-Villoslada F, De Haro O, Camuesco D, et al,. Short-chain fructo oligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr 2006; 45: 418-25.
34. Segain JP, Raingeard D, de la Bletiere D, et al,. Butyrate inhibits inflammatory responses through NFkB inhibition: implications for Crohn's disease. Gut 2000; 47: 397-403.
35. Marquet P, Duncan SH, Chassard C, Bernalier-Donadille A, Flint HJ,. Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett 2009; 299: 128-34.
36. Sasaki M, Klapproth MA,. The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduct 2012; 2012: 704953.
37. Immerseel F, Ducatelle R, De Vos M, et al,. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 2010; 59: 141-2.